Published in Crit Care Med on July 01, 2006
Shorter time to target temperature is associated with poor neurologic outcome in post-arrest patients treated with targeted temperature management. Resuscitation (2014) 1.58
Active surface cooling protocol to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a single hospital. Crit Care Med (2009) 1.54
Automated peritoneal lavage: an extremely rapid and safe way to induce hypothermia in post-resuscitation patients. Crit Care (2013) 1.46
Targeted temperature management after out-of-hospital cardiac arrest: who, when, why, and how? Can Fam Physician (2015) 1.39
Clinical review: Prognostic value of magnetic resonance imaging in acute brain injury and coma. Crit Care (2007) 1.14
Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system. Crit Care (2007) 1.09
Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines? Eur Heart J Acute Cardiovasc Care (2012) 1.01
Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls. Crit Care (2008) 0.98
Brain resuscitation in the drowning victim. Neurocrit Care (2012) 0.93
The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function. Expert Opin Drug Metab Toxicol (2011) 0.92
Out-of-hospital therapeutic hypothermia in cardiac arrest victims. Scand J Trauma Resusc Emerg Med (2009) 0.90
Incidence of re-arrest and critical events during prolonged transport of post-cardiac arrest patients. Resuscitation (2010) 0.90
The practice of therapeutic hypothermia after cardiac arrest in France: a national survey. PLoS One (2012) 0.87
Coma due to cardiac arrest: prognosis and contemporary treatment. F1000 Med Rep (2009) 0.84
Therapeutic hypothermia is associated with a decrease in urine output in acute stroke patients. Resuscitation (2010) 0.83
The effect of hypothermia "dose" on vasopressor requirements and outcome after cardiac arrest. Resuscitation (2012) 0.83
Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest. Crit Care (2007) 0.83
Therapeutic hypothermia: is it effective for non-VF/VT cardiac arrest? Crit Care (2013) 0.82
Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Resuscitation (2011) 0.81
Short- and long-latency somatosensory neuronal responses reveal selective brain injury and effect of hypothermia in global hypoxic ischemia. J Neurophysiol (2011) 0.80
Comparison of whole-body cooling and selective head cooling on changes in urinary 8-hydroxy-2-deoxyguanosine levels in patients with global brain ischemia undergoing mild hypothermia therapy. Med Sci Monit (2012) 0.79
Long-Term Effects of Induced Hypothermia on Local and Systemic Inflammation - Results from a Porcine Long-Term Trauma Model. PLoS One (2016) 0.78
Therapeutic hypothermia protocol in a community emergency department. West J Emerg Med (2010) 0.78
Using vascular closure devices following out-of-hospital cardiac arrest? Int J Med Sci (2015) 0.78
Moderately lower temperatures greatly extend the lifespan of Brachionus manjavacas (Rotifera): Thermodynamics or gene regulation? Exp Gerontol (2016) 0.77
Mild induced hypothermia after out-of-hospital cardiac arrest: persisting doubts about patient safety. Crit Care (2007) 0.77
Use of hypothermia in the intensive care unit. World J Crit Care Med (2012) 0.77
Earlier Hypothermia Attainment is Associated with Improved Outcomes after Cardiac Arrest. J Vasc Interv Neurol (2011) 0.77
Therapeutic applications of hypothermia in cerebral ischaemia. Ther Adv Neurol Disord (2008) 0.76
Cardiac Arrest Disrupts Caspase-1 and Patterns of Inflammatory Mediators Differently in Skin and Muscle Following Localized Tissue Injury in Rats: Insights from Data-Driven Modeling. Front Immunol (2015) 0.76
Therapeutic hypothermia. Korean J Anesthesiol (2010) 0.76
Mild therapeutic hypothermia in patients resuscitated from out-of-hospital cardiac arrest: A meta-analysis of randomized controlled trials. Ann Card Anaesth (2016) 0.76
Therapeutic hypothermia for anoxic brain injury following cardiac arrest: a "cool" transition toward cardiopulmonary cerebral resuscitation. Crit Care Med (2006) 0.76
Improving neurological outcome after cardiac arrest: Therapeutic hypothermia the best treatment. Anesth Essays Res (2015) 0.75
Favorable Outcome and Survival Using a Hypothermia Protocol After Successful Cardiopulmonary Resuscitation. J Clin Med Res (2015) 0.75
Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest - an analysis of the TTM trial data. Crit Care (2016) 0.75
Similar long-term survival of consecutive in-hospital and out-of-hospital cardiac arrest patients treated with targeted temperature management. Clin Epidemiol (2016) 0.75
The Role of Targeted Temperature Management in Adult Patients Resuscitated from Nonshockable Cardiac Arrests: An Updated Systematic Review and Meta-Analysis. Biomed Res Int (2016) 0.75
Therapeutic hypothermia for out-of-hospital cardiac arrest: An analysis comparing cooled and not cooled groups at a Canadian center. J Emerg Trauma Shock (2012) 0.75
Implementation of a post-arrest care team: understanding the nuances of a team-based intervention. Implement Sci (2016) 0.75
[Therapeutic hypothermia after cardiopulmonary resuscitation - pro and con]. Wien Med Wochenschr (2008) 0.75
Factors Influencing the Quality of Standardized Treatment for Patients with Post-Cardiac Arrest Syndrome. Korean Circ J (2017) 0.75
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Early predictors of outcome in comatose survivors of ventricular fibrillation and non-ventricular fibrillation cardiac arrest treated with hypothermia: a prospective study. Crit Care Med (2008) 3.14
Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology (2009) 2.83
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol (2007) 2.81
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation (2003) 2.56
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes (2002) 2.20
Ventricular arrhythmia in coronary artery disease: limits of a risk stratification strategy based on the ejection fraction alone and impact of infarct localization. Europace (2009) 2.07
The vasodilatory response of skin microcirculation to local heating is subject to desensitization. Microcirculation (2009) 2.02
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med (2006) 1.99
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med (2002) 1.97
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol (2009) 1.89
Body temperature regulation and outcome after cardiac arrest and therapeutic hypothermia. Resuscitation (2011) 1.78
CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol (2007) 1.77
Management of mechanical ventilation in acute severe asthma: practical aspects. Intensive Care Med (2006) 1.76
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol (2004) 1.67
Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain. Intensive Care Med (2014) 1.64
Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive disease: A prospective, multicenter study. Crit Care Med (2003) 1.62
Format of medical order sheet improves security of antibiotics prescription: The experience of an intensive care unit. Crit Care Med (2004) 1.59
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol (2010) 1.56
Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest. Crit Care Med (2011) 1.56
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol (2007) 1.54
Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: the intensive care unit dietitian can make the difference. Crit Care Med (2012) 1.53
Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci (2005) 1.53
Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery (2011) 1.51
Impact of low pulmonary vascular pressure on ventilator-induced lung injury. Crit Care Med (2002) 1.49
Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock (2002) 1.44
Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med (2006) 1.42
Sepsis up-regulates the expression of connexin 40 in rat aortic endothelium. Crit Care Med (2005) 1.40
Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography. Circ J (2011) 1.40
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol (2007) 1.39
Pulse wave analysis of aortic pressure: diastole should also be considered. J Hypertens (2013) 1.39
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J Am Coll Cardiol (2002) 1.36
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol (2007) 1.34
A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J Pharmacol Exp Ther (2004) 1.32
Hypertension and microvascular remodelling. Cardiovasc Res (2008) 1.26
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free Radic Biol Med (2011) 1.24
Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res (2002) 1.23
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res (2009) 1.22
Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. Int J Mol Med (2006) 1.21
Hypertension: a disease of the microcirculation? Hypertension (2006) 1.21
Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia (2004) 1.20
Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner. J Biol Chem (2010) 1.19
Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care (2010) 1.18
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncol Rep (2004) 1.18
Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia. Resuscitation (2013) 1.17
Accuracy of prehospital triage of trauma patients by emergency physicians: a retrospective study in western Switzerland. Eur J Emerg Med (2011) 1.14
Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J Biol Chem (2005) 1.13
Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation. Br J Pharmacol (2002) 1.12
Evaluation of an online, case-based interactive approach to teaching pathophysiology. Med Teach (2008) 1.10
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes (2012) 1.10
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology (2014) 1.09
Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res (2004) 1.08
The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep (2009) 1.07
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med (2008) 1.05
Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis. Biochem Biophys Res Commun (2006) 1.04
Caspase-3 protects stressed organs against cell death. Mol Cell Biol (2012) 1.03
Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med (2002) 1.03
Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit (2004) 1.03
Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med (2012) 1.02
Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management. Crit Care (2012) 1.00
The role of oxidative stress during inflammatory processes. Biol Chem (2014) 0.99
Dose-dependent vasodilatory effects of acetylcholine and local warming on skin microcirculation. J Cardiovasc Pharmacol (2004) 0.99
Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovasc Res (2010) 0.98
Homocysteine induces cell death in H9C2 cardiomyocytes through the generation of peroxynitrite. Biochem Biophys Res Commun (2007) 0.98
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol (2010) 0.97
Blunted vasodilatory responses in the cutaneous microcirculation of cigarette smokers. Am Heart J (2002) 0.95
Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am J Physiol Heart Circ Physiol (2010) 0.95
Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol (2002) 0.94
Effects of L-NAME and inhaled nitric oxide on ventilator-induced lung injury in isolated, perfused rabbit lungs. Crit Care Med (2004) 0.94
Acute inflammation decreases the expression of connexin 40 in mouse lung. Shock (2007) 0.94
Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol Med (2002) 0.93
Poly(ADP-ribose)polymerase inhibition decreases angiogenesis. Biochem Biophys Res Commun (2006) 0.93
Acetylcholine-induced vasodilation and reactive hyperemia are not affected by acute cyclo-oxygenase inhibition in human skin. Microcirculation (2004) 0.92
Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study. Intensive Care Med (2008) 0.91
Are terminally ill patients dying in the ICU suitable for non-heart beating organ donation? Intensive Care Med (2006) 0.90
Endurance training enhances vasodilation induced by nitric oxide in human skin. J Invest Dermatol (2003) 0.90
Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice. Crit Care (2010) 0.89